[edit] Company Activities
|
|
Proteome Sciences has developed ProteoSHOP®, a toolkit of gel-based and gel-free proteomics technologies to address differential protein expression in disease and therapy. In addition to considerable expertise across the generic technologies which make up proteomics, Proteome Sciences has built up a range of proprietary techniques including PST®, qPST™ and TMT® for the gel-free identification and relative quantitation of proprietary proteins in cells, body fluids and tissues with a strong focus on membrane and nuclear proteins. These applications overcome the considerable levels of difficulty and complexity of existing technologies and have been successfully used and validated across a broad range of human diseases and model systems.
|
[edit] Key Investor Issues
|
|
Details of Key Investor Issues here
|
|
|
|
Details of Risks here
|
|
[edit] Delayed Share Price Information
|
| PRM Share Price Quote
| 22.50
|
| PRM Share Price Change
| -0.75
|
| PRM Share Price High
| 22.75
|
| PRM Share Price Low
| 20.50
|
| PRM Share Price Open
| 22.50
|
| PRM Share Price Volume
| 412,578
|
|
[edit] Research Links
|
|
Details of Research Links here
|
|